Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Business Development
13 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Business Development
Strategizing for International Business Development
PAP-Q3-19-CL-029
Facilitating Acquisitions
Facilitating Pharmaceutical and Biotech Facility Acquisitions
PAP-Q3-19-CL-021
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
PR-M07-19-NI-047
Announcement
GSK Announces Changes to Their Sales Representative Incentive Program
PR-M05-19-NI-083
Business Development
Running a CDMO Business is Hard – So Now Let’s Talk about Value Creation
PAP-Q2-2019-CL-015
Launch
Piramal Announces the Launch of Cinacalcet by its Partner, Slate Run Pharmaceuticals, in the U.S.
PR-M03-19-NI-034
Attracting Investment
Preparing Middle-Market Firms to Attract Investment
PAP-Q1-2019-CL-007
Q of E
Quality of Earnings: The Most Important Term You Probably Don’t Know
PAP-Q1-2019-CL-022
Consolidation
Factors Driving Consolidation in the CDMO Space
PAP-Q1-2019-CL-023
Leveraging Expertise
Similar, Different and Constantly Varied
PAP-Q1-2019-CL-021
The U.K. Market
U.K. Healthcare Firms Creating Value Worldwide
PAP-Q1-2019-CL-027
Risk Management
The Value Triangle: Risk Management for RMATs
PAP-Q1-2019-CL-018
Generics
Finding the Right Product Platform: A Personal Perspective
PAP-Q1-2019-CL-034
